BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23974720)

  • 1. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer.
    Zhu Y; Zhang H; Li Y; Bai J; Liu L; Liu Y; Qu Y; Qu X
    Cancer Immunol Immunother; 2013 Oct; 62(10):1629-35. PubMed ID: 23974720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
    Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
    Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.
    Li Y; Wang C; Xu M; Kong C; Qu A; Zhang M; Zheng Z; Zhang G
    J Cancer Res Clin Oncol; 2017 May; 143(5):861-871. PubMed ID: 28108815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer.
    Li DP; Li W; Feng J; Chen K; Tao M
    Oncol Res; 2015; 22(2):67-74. PubMed ID: 25706393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
    Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
    Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.
    Shi L; Zhou Q; Wu J; Ji M; Li G; Jiang J; Wu C
    Cancer Immunol Immunother; 2012 Dec; 61(12):2251-9. PubMed ID: 22674056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
    Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
    Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
    Zhang J; Zhu L; Zhang Q; He X; Yin Y; Gu Y; Guo R; Lu K; Liu L; Liu P; Shu Y
    Biomed Pharmacother; 2014 Jul; 68(6):715-20. PubMed ID: 25107840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies.
    Zhang C; Zhang Z; Wang L; Han J; Li F; Shen C; Li H; Huang L; Zhao X; Yue D; Huang J; Yan Y; Zhang Y
    Int Immunopharmacol; 2017 Oct; 51():57-65. PubMed ID: 28802902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
    Wang ZX; Cao JX; Liu ZP; Cui YX; Li CY; Li D; Zhang XY; Liu JL; Li JL
    World J Gastroenterol; 2014 Jan; 20(4):1095-106. PubMed ID: 24574784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.
    Zhao X; Ji CY; Liu GQ; Ma DX; Ding HF; Xu M; Xing J
    Int J Clin Exp Pathol; 2015; 8(10):13146-55. PubMed ID: 26722513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.
    Chang B; Shen L; Wang K; Jin J; Huang T; Chen Q; Li W; Wu P
    Liver Int; 2018 Aug; 38(8):1449-1458. PubMed ID: 29356308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.
    Chen JL; Lao XM; Lin XJ; Xu L; Cui BK; Wang J; Lin GH; Shuang ZY; Mao YZ; Huang X; Yun JP; Jin JT; Li SP
    Medicine (Baltimore); 2016 Feb; 95(5):e2665. PubMed ID: 26844496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.